Abstract
The endocannabinoid 2-arachidonoylglycerol (2-AG) enhances cell migration through the CB2 cannabinoid receptor. In this study, using an immunoprecipitation and mass spectrometry-based proteomic approach, we first identified the 90-kDa heat shock protein (Hsp90), a chaperone protein with novel signaling functions, as a CB2-interacting protein. The CB2/Hsp90 interaction was confirmed in human embryonic kidney 293 cells expressing transfected CB2 and in differentiated HL-60 cells expressing endogenous CB2, by coimmunoprecipitation and Western blot experiments, as well as by treatment with geldanamycin (GA), a specific Hsp90 inhibitor. Disruption of the CB2/Hsp90 interaction by treatment with GA or reducing Hsp90 levels with specific short interfering RNAs markedly inhibited 2-AG-induced cell migration, demonstrating that Hsp90 is crucial for 2-AG-induced cell migration. 2-AG treatment resulted in a CB2-mediated stimulation of Rac1 activity, and treatment with GA blocked 2AG-induced activation of Rac1. It is noteworthy that expression of the dominant-negative form of Rac1 reduced 2-AG-induced cell migration. These data demonstrate that 2-AG-induced activation of Rac1 is essential for 2-AG-induced cell migration, and the CB2/Hsp90 interaction is needed for 2-AG-induced activation of Rac1. Furthermore, 2-AG-induced Rac1 activation was sensitive to pertussis toxin treatment, hence involving Gi proteins. In addition, treatment with GA significantly inhibited the CB2/Gαi2 interaction. As a whole, our data indicate that Hsp90 may serve as scaffold to keep the CB2 receptor and its signaling components, including Gαi2, in proximity, thus facilitating CB2-mediated signaling to cell migration through the Gi-Rac1 pathway. By demonstrating that Hsp90 is essential for CB2-mediated signaling to cell migration, this study reveals a novel role of Hsp90 in the signaling events mediated by a G protein-coupled receptor.
Footnotes
-
This work is supported in part by National Institutes of Health grants DA11551 and EY13632.
-
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
-
doi:10.1124/mol.107.036566.
-
ABBREVIATIONS: GPCR, G protein-coupled receptor; CB, cannabinoid; 2-AG, 2-arachidonoylglycerol; Hsp90, 90-kDa heat shock protein; HEK, human embryonic kidney; SR144528, SR2, N-[(1S)-endo-1,3,3-trimethyl-bicyclo-[2.2.1]-heptan-2-yl]-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-pyrazole-3-carboxamide; siRNA, short interfering RNA; DMEM, Dulbecco's modified Eagle's medium; DMSO, dimethyl sulfoxide; MALDI-TOF, matrix-assisted laser desorption ionization/time of flight; MS, mass spectrometry; PAGE, polyacrylamide gel electrophoresis; ACN, acetonitrile; TBS-T, Tris-buffered saline/Tween 20; ANOVA, analysis of variance; PTX, pertussis toxin; GA, geldanamycin; PAK-PBD-GST, p21-activated kinase-PAK binding domain-glutathionetransferase.
- Received March 28, 2007.
- Accepted August 14, 2007.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|